Diabetes technology

Simplifying meal bolusing with Omnipod 5: real-world outcomes to support simplified user-initiated insulin dosing strategies in managing type 1 or type 2 diabetes

Diabetes Res Clin PractPublished Retrospective cohort study

Authors' conclusion

Glycemic outcomes with simplified bolusing were non-inferior to carbohydrate counting, suggesting carbohydrate counting ability should not affect AID access.

Study context

Population
Omnipod 5 automated insulin delivery (AID) users with T1D or T2D in the US, UK, France and Germany, 01/01/25–31/03/2592 % T1D
Participants
195,529 participants
Exposure
Simplified meal bolusing vs carbohydrate counting
Outcome
Glycemic outcomes (TIR 70-180 mg/dL, TBR <70 mg/dL, mean glucose), non-inferiority of simplified bolusing vs carbohydrate counting
Methodological detailsreal-world data, non-inferiority, quantile regression, adjusted for user characteristics and device settings/usage
  • Real-world data
  • Non-inferiority
  • Quantile regression, adjusted for user characteristics and device settings/usage

Main finding

As reported in the abstract

Glycemic outcomes in T1D

Difference in time in range (TIR) 70-180 mg/dL

2.5 % lower

Simplified bolusing

Difference in time below range (TBR) < 70 mg/dL

0.19 % lower

Simplified bolusing

Difference in mean glucose

5 mg/dL higher

Simplified bolusing

Observational data: associations, not effects.

Further findings

T2D: TIR 70-180 mg/dL, TBR <70 mg/dL and mean glucose, simplified bolusing vs carbohydrate counting

Difference in TIR
- 1.7 %
Difference in TBR
−0.05 %
Difference in mean glucose
+ 4 mg/dL
All met noninferiority

T1D subgroups by age group and country

All endpoints met noninferiority, with similar findings across age groups and countries

Users with optimized settings and expected use patterns

T1D maintained noninferiority
T2D met noninferiority for TBR only

Original publication

Simplifying meal bolusing with Omnipod 5: real-world outcomes to support simplified user-initiated insulin dosing strategies in managing type 1 or type 2 diabetes. Diabetes Res Clin Pract. Published 17 July 2026. doi:10.1016/j.diabres.2026.113450

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.